ClinConnect ClinConnect Logo
Search / Trial NCT05247645

Data Collection of Patients With Rare Bone Diseases

Launched by LUCA SANGIORGI · Feb 9, 2022

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Rare Disease With Predominantly Skeletal Involvement Skeletal Disorders Data Collection Natural History Study

ClinConnect Summary

The RD-DATA clinical trial is focused on collecting important information about patients with rare bone diseases, specifically conditions called skeletal dysplasias. This study aims to gather various types of data, such as personal health information, genetic details, and surgical histories, to better understand these diseases. By looking at how genetics might influence the symptoms and outcomes of these conditions, the researchers hope to gain insights that can improve care and treatment for patients.

Anyone with a rare disease that affects the bones may be eligible to participate, regardless of age or gender. However, individuals with conditions unrelated to these rare bone diseases will not be included. Participants in this study can expect to share their medical information, which will be used to help researchers learn more about the diseases. This trial is currently recruiting, and by joining, patients will contribute to important research that may lead to better understanding and management of skeletal dysplasias in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients affected by rare diseases with predominantly skeletal involvement
  • Exclusion Criteria:
  • Any condition unrelated to rare diseases with predominantly skeletal involvement

About Luca Sangiorgi

Luca Sangiorgi is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapies, Luca Sangiorgi leads initiatives that emphasize patient safety, scientific rigor, and ethical standards. The organization collaborates with leading research institutions and healthcare professionals to conduct clinical trials across various therapeutic areas, aiming to bring impactful treatments to market. Through strategic partnerships and a strong emphasis on data integrity, Luca Sangiorgi strives to enhance patient outcomes and contribute to the evolution of healthcare.

Locations

Bologna, Emilia Romagna, Italy

Patients applied

0 patients applied

Trial Officials

Luca Sangiorgi, MD, PhD

Principal Investigator

IRCCS istituto Ortopedico Rizzoli

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials